文献速递角膜与眼表疾病

角膜中肌源性分化基因MyoD的表达及其在角膜肌成纤维细胞去分化中的作用

Myogenic Differentiation (MyoD) Gene Expression in Cornea and Role in Corneal Myofibroblast Dedifferentiation.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2026-01-01

本研究检测了MyoD在非纤维化和纤维化兔及人供体角膜中的表达,并在体外和体内研究MyoD基因沉默对角膜肌成纤维细胞去分化和纤维化的影响。结果显示纤维化角膜和角膜肌成纤维细胞中MyoD水平显著升高,沉默MyoD可促使肌成纤维细胞向成纤维细胞表型转化并减少纤维化基因表达。

要点

  • 纤维化人角膜和兔角膜中MyoD水平显著高于非纤维化角膜。
  • 角膜肌成纤维细胞中MyoD水平显著高于角膜基质成纤维细胞。
  • 沉默MyoD可降低αSMA、FN、ColI、ColIV mRNA并改变细胞表型。

核心结论

  • MyoD在角膜中表达,可改善角膜肌成纤维细胞去分化和损伤角膜的纤维化。
  • 需进一步研究确定MyoD在角膜纤维化管理中的潜力。

研究设计与样本

  • 使用新西兰白兔、人供体角膜、人角膜基质成纤维细胞(CSFs)和人角膜肌成纤维细胞(CMFs)。
  • 通过Lipofectamine 3000将MyoD shRNA或乱序shRNA递送至CMFs,通过2-kDa聚乙烯亚胺偶联金纳米颗粒(PEI2-GNPs)递送至兔角膜。
  • 采用qRT-PCR、免疫荧光和western blotting定量检测CMF中MyoD基因沉默后的促纤维化基因、中间丝、成纤维细胞特异性蛋白1(FSP1)和增殖标记Ki67的表达。

主要发现

  • MyoD在人及兔角膜上皮、基质和内皮中均可检测到。
  • 纤维化人角膜MyoD水平显著高于对应非纤维化角膜(P < 0.001),纤维化兔角膜亦显著高于对应非纤维化角膜(P < 0.0001)。
  • CMFs的MyoD水平显著高于CSFs(P < 0.0001)。
  • MyoD shRNA沉默的CMFs获得典型成纤维细胞表型,且αSMA(P < 0.0001)、FN(P = 0.0015)、ColI(P = 0.0011)和ColIV(P = 0.0053)mRNA水平较乱序shRNA组降低。
  • MyoD shRNA沉默的CMFs中波形蛋白(P < 0.001)、FSP1(P < 0.01)和Ki67(P = 0.0349)表达增加,结蛋白表达减少(P < 0.001)。

临床怎么用

  • MyoD可作为角膜纤维化管理的潜在靶点,但尚需进一步研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Myogenic differentiation (MyoD), a class II basic helix-loop-helix transcription factor, regulates multiple cell functions, including fibrosis in many organs, but remains unknown in the cornea. This study characterized the expression of MyoD in non-fibrotic and fibrotic rabbit and human donor corneas and investigated the effects of MyoD gene silencing on corneal myofibroblast dedifferentiation in vitro and fibrosis in vivo. METHODS: New Zealand White rabbits, human donor corneas, human corneal stromal fibroblasts (CSFs), and human corneal myofibroblasts (CMFs) were used. MyoD shRNA or scrambled shRNA was delivered into CMFs via Lipofectamine 3000 and rabbit cornea via 2-kDa polyethylenimine conjugated to gold nanoparticles (PEI2-GNPs). Quantitative real-time polymerase chain reaction (qRT-PCR), immunofluorescence, and western blotting quantified the expression of profibrotic genes, intermediate filaments, fibroblast-specific protein 1 (FSP1), and proliferation marker Ki67 in CMF-/+ MyoD gene silencing. RESULTS: MyoD expression was detected in human and rabbit corneal epithelium, stroma, and endothelium. MyoD levels were significantly greater in fibrotic human corneas (P < 0.001) and rabbit corneas (P < 0.0001) than corresponding non-fibrotic corneas. Also, CMFs had significantly greater MyoD levels than CSFs (P < 0.0001). MyoD shRNA-silenced CMFs acquired a characteristic fibroblast phenotype and showed reduced fibrotic genes, alpha smooth muscle actin (αSMA; P < 0.0001), fibronectin (FN; P = 0.0015), collagen type I (ColI; P = 0.0011), and collagen type IV (ColIV; P = 0.0053) mRNA levels compared to the scrambled shRNA-delivered CMFs. Further, immunofluorescence demonstrated increased vimentin (P < 0.001), FSP1 (P < 0.01), and Ki67 expression (P = 0.0349) and decreased desmin expression (P < 0.001) in MyoD shRNA-silenced CMFs than the scrambled shRNA-delivered CMFs. MyoD shRNA-delivered rabbit corneas had less scarring in vivo (P = 0.368). CONCLUSIONS: MyoD is expressed in cornea and could amend CMF dedifferentiation and fibrosis in an injured cornea. Additional studies are warranted to define the potential of MyoD in corneal fibrosis management.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Tripathi R, Sinha NR, Sood S, et al. Myogenic Differentiation (MyoD) Gene Expression in Cornea and Role in Corneal Myofibroblast Dedifferentiation. Invest Ophthalmol Vis Sci. 2026. PMID: 41784334. doi:10.1167/iovs.67.3.7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。